Belgium, Switzerland, Germany, Spain, France, United Kingdom, Liechtenstein, Luxembourg, Netherlands
Fund manager biographies
Name
Not Disclosed
Since
01 January 1900
Bio
Fund objective
Objectives and Investment Policy The Sub-Fund is actively managed in reference to a benchmark. The Bloomberg Barclays US Corporate (the “Benchmark”) is used for performance comparison and for internal risk monitoring purposes. Bond issuers represented in the portfolio of the Sub-Fund will generally be similar to those of the Benchmark however, their weightings are expected to differ to a certain extent and the Investment Manager has discretion to select issuers that are not part of the Benchmark universe. This may limit the outperformance of the Sub-Fund compare to that of its Benchmark. The Sub-Fund's objective is to outperform the benchmark. It mainly invests in debt securities, denominated in USD and issued in the US market by corporate issuers, including debt securities of foreign issuers issued in the US market and debt securities issued simultaneously in the Eurobond and US bond markets. In addition, the Sub-Fund may invest in ABS/MBS up to 15% of its net assets. The Investment Manager will mainly invest in investment grade debt obligations and will take into consideration the quality and diversity of issuers and sectors, along with the maturity date. Information - Recommendation: This Sub-Fund may not be appropriate for investors who plan to withdraw their money within 3 years. - Dealing frequency: You may redeem shares in this Sub-Fund on demand on a daily basis. - The Sub-Fund is denominated in USD. This Class is in USD. - Distribution policy: Income distribution (November).